CNS Pharmaceuticals Market Cap

CNS Pharmaceuticals has a market cap or net worth of $1.89 million as of March 9, 2026. Its market cap has decreased by -66.47% in one year.

Market Cap

1.89M

Enterprise Value

-7.97M

1-Year Change

-66.47%

Ranking

#5499

Market Cap Chart

Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $1.89M, a decrease of -97.30%. That is a compound annual growth rate of -43.50%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	1.82M	-44.00%
Dec 31, 2025	3.26M	-52.95%
Dec 31, 2024	6.92M	4.40%
Dec 29, 2023	6.63M	109.26%
Dec 30, 2022	3.17M	-83.83%
Dec 31, 2021	19.60M	-51.07%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Calidi Biotherapeutics	2.64M
60 Degrees Pharmaceuticals	2.64M
Artelo Biosciences	2.42M
PMGC Holdings	2.40M
Bone Biologics	2.30M
Lyra Therapeutics	2.27M
Clearmind Medicine	2.05M
Adial Pharmaceuticals	2.03M

Market Cap Rankings